Autopsy report · NCT01913197

Using Magnetic Resonance Imaging (MRI) to Guide Differential-Dose Prostate Brachytherapy

Cause of deathSlow enrollment Automatic label, confidence 0.9, unverified. How labels are made.

“low enrollment”

The sponsor’s own words in the registry.

Life of this trial

Ran for about 3 years 3 months before it stopped.
2 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 1, Phase 2
Sponsor: St. Luke's-Roosevelt Hospital Center
Sponsor type: University, hospital or other
Conditions: Prostate Cancer
Interventions: An MRI-based technique to identify prostate cancer
Participants: 2
Sites: 1
Countries: United States

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.